Saturday 17 October 2026
Export BGMS’s income statement to Excel — free account
Bio Green Med Solution, Inc.
BGMS Healthcare Biotechnology
Bio Green Med Solution, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747,000.00, up 1,637.2% from fiscal 2024. In the quarter to June 2026, revenue grew 3,260.0%, EPS grew 91.8% and free cash flow grew 66.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.91
0.08
+9.64%
Follow BGMS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | — | — | — | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | — | — | — | — | 0.00 | — | 0.00 |
Altman Z-Score |
(78.86) | (160.52) | (77.52) | — | — | — | — | (24.20) | — | — |
P/S ratio |
4.25 | 27.48 | 3.19 | — | — | — | — | 10.42 | — | 0.00 |
Altman Z″-Score (non-manufacturers) |
(178.61) | (374.19) | (178.45) | — | — | — | — | (52.16) | — | (52.81) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | — | — | — | 0.00 | — | 0.00 |
P/Operating CF |
(98.00) | (1.50) | (0.57) | — | — | — | — | (4.31) | — | 0.00 |
P/B ratio |
0.47 | 0.00 | 3.67 | — | — | — | — | 0.58 | — | 0.00 |
Dividend Safety Score |
20 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
0.61 | 0.00 | 3.67 | — | — | — | — | 0.58 | — | 0.00 |
EV/Sales |
(0.36) | (14.91) | (1.65) | — | — | — | — | (10.34) | — | (19.60) |
EV/EBITDA |
0.03 | 0.09 | 0.05 | — | — | — | — | 0.90 | — | 1.18 |
EV/Operating CF |
0.06 | 0.14 | 0.07 | — | — | — | — | 1.30 | — | 1.64 |
EV/FCF |
0.06 | 0.14 | 0.07 | — | — | — | — | 1.31 | — | 1.65 |
Quick Ratio |
3.58 | 0.50 | 0.41 | 3.06 | 7.44 | 13.97 | 5.46 | 4.27 | 6.18 | 3.53 |
Current Ratio |
4.70 | 0.59 | 0.91 | 3.25 | 7.56 | 14.27 | 5.79 | 4.45 | 6.32 | 3.73 |
Net Debt/EBITDA |
0.42 | 0.26 | 0.13 | 0.66 | 1.64 | 3.15 | 1.23 | 1.84 | 2.53 | 1.18 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.12 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.04 |
Operating CF/Net income |
0.34 | 0.71 | 0.71 | 0.97 | 0.99 | 0.64 | 1.18 | 0.89 | 0.50 | 0.84 |
Capex/Depreciation |
0.00 | 0.00 | (0.19) | (0.22) | (0.63) | (4.80) | 1.40 | (1.34) | (0.41) | 0.07 |
| (603.77%) | 1,431.01% | (275.06%) | (79.80%) | (52.59%) | (55.26%) | (59.56%) | (40.44%) | (82.39%) | (72.44%) | |
| (229.53%) | (173.84%) | (123.49%) | (60.12%) | (46.68%) | (47.67%) | (45.72%) | (32.68%) | (65.02%) | (53.98%) | |
ROIC |
(157.83%) | 0.00% | 0.00% | 0.00% | (1,233.96%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(278.44%) | 432.73% | 3,214.12% | (126.38%) | (52.42%) | (37.54%) | (69.09%) | (48.72%) | (67.82%) | (83.25%) |
Average Days of Receivables |
614.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,659.73 | 0.00 | 890.63 |
Research and Development Expense of Revenue |
113.52% | 15,476.74% | 4,560.71% | 0.00% | 0.00% | 0.00% | 0.00% | 2,884.67% | 0.00% | 1,124.20% |
Selling, General and Administrative Expense of Revenue |
1,033.07% | 12,539.53% | 1,599.52% | 0.00% | 0.00% | 0.00% | 0.00% | 3,580.67% | 0.00% | 654.33% |
Intangible Assets out of Total Assets |
0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
312.45% | 1,376.74% | 350.71% | 0.00% | 0.00% | 0.00% | 0.00% | 220.67% | 0.00% | 92.76% |
Graham Net Nets |
1.52 | (1.28) | (0.34) | — | — | — | — | 1.73 | — | 0.00 |
Graham Number |
0.00 | 849.61 | 0.00 | — | — | — | — | 0.00 | — | 0.00 |
Earnings Yield |
(319.04%) | (360.83%) | (767.51%) | — | — | — | — | (101.94%) | — | (88.41%) |
Free Cash Flow Yield |
(144.71%) | (388.44%) | (719.77%) | — | — | — | — | (75.64%) | — | 0.00% |
Revenue per Share |
0.34 | 1.93 | 120.00 | 0.00 | 0.00 | 0.00 | 0.00 | 750.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.18) | (358.30) | (4,603.43) | (7,713.70) | (7,416.00) | (7,934.00) | (47,235.00) | (33,505.00) | (74,800.00) | 0.00 |
Capex per Share |
0.00 | 0.00 | (1.71) | (2.59) | (10.80) | (96.00) | 140.00 | (195.00) | (130.00) | 0.00 |
Free Cash Flow per Share |
(2.18) | (358.30) | (4,605.14) | (7,716.30) | (7,426.80) | (8,030.00) | (47,095.00) | (33,700.00) | (74,930.00) | 0.00 |
Cash per Share |
1.60 | 140.67 | 965.14 | 6,794.44 | 14,623.60 | 33,406.00 | 59,425.00 | 87,520.00 | 239,100.00 | 0.00 |
Shareholders Equity per Share |
3.13 | (97.49) | 173.43 | 5,903.33 | 15,077.20 | 33,259.00 | 58,485.00 | 76,360.00 | 217,660.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.13 | (97.49) | 173.43 | 5,903.33 | 15,077.20 | 33,259.00 | 58,485.00 | 76,360.00 | 217,660.00 | 0.00 |
Free Cash Flow |
(4.77) | (7.99) | (16.12) | (20.83) | (18.57) | (8.03) | (9.42) | (6.74) | (7.49) | (10.07) |
Working Capital |
4.92 | (2.59) | (0.72) | 16.90 | 35.53 | 32.98 | 11.60 | 15.34 | 21.86 | 14.36 |
Capital Expenditures |
— | — | (0.01) | (0.01) | (0.03) | (0.10) | 0.03 | (0.04) | (0.01) | 0.01 |
Net Current Asset Value |
4.91 | (2.59) | (0.75) | 12.30 | 35.50 | 31.93 | 10.41 | 15.24 | 21.74 | 14.23 |
EV/EBIT |
0.03 | 0.09 | 0.05 | — | — | — | — | 0.91 | — | 1.17 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.26 | 0.00 | (0.01) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — | — | — | — | 0.00 | — | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.04 | 2.00 | 3.44 | 1.00 | 0.67 | 0.19 | 0.74 | 0.81 | 1.10 | 2.96 |
Cash ROIC |
(46.10%) | (829.70%) | (404.47%) | (60.77%) | (25.01%) | (12.05%) | (39.94%) | (20.56%) | (16.40%) | (32.70%) |
Accounts Receivable Turnover |
0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.48 |
Accounts Payable Turnover |
0.23 | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.01 | 0.00 | 0.02 | 0.00 |
Inventory Turnover |
0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Average Days of Payables |
369.79 | 0.00 | 0.00 | 29,211.41 | 17,969.88 | 9,380.50 | 16,242.50 | 0.00 | 17,770.94 | 0.00 |
Days of Inventory on Hand |
829.49 | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — |
Average Receivables |
2.96 | — | — | 4.20 | 2.52 | 1.32 | 1.42 | 1.50 | 1.77 | 1.77 |
Average Payables |
2.61 | 4.07 | 3.05 | 2.34 | 1.32 | 0.70 | 1.80 | 2.14 | 2.03 | 2.22 |
Average Assets |
6.14 | 6.45 | 18.43 | 35.59 | 39.97 | 26.06 | 17.57 | 22.91 | 22.83 | 22.21 |
Average Common Equity |
2.33 | (0.78) | 8.27 | 26.82 | 35.48 | 22.48 | 13.48 | 18.52 | 18.02 | 16.55 |
Columns are period end dates